PT-141 (Bremelanotide) 10mgPT-141 (Bremelanotide) 10mg
A melanocortin receptor agonist with a narrow US licensed indication for acquired, generalised HSDD in premenopausal women.
Answer a short online consultation. A clinician reviews it, and you only pay if treatment is approved. Dispensed by our licensed facility.
What it is
Bremelanotide, also known as PT-141, is a synthetic cyclic peptide developed from melanocortin analogue work. It acts at melanocortin receptors, with central MC4 receptor activity relevant to sexual desire.
In the USA, an authorised bremelanotide product has a specific indication for acquired, generalised hypoactive sexual desire disorder in premenopausal women. It is not licensed there for men, postmenopausal women or enhancement of sexual performance.
Why people ask about it
People ask about low desire and intimacy, but assessment must distinguish distressing low desire from medication effects, relationship factors and other medical causes.
What the science says
The two phase III RECONNECT trials studied premenopausal women with acquired, generalised HSDD and reported improvements in desire and related distress measures versus placebo. These findings do not validate a generic 10mg preparation or establish broad benefits across sexes and diagnoses.
Is it right for me?
For PT-141, online consultation and clinician approval are required before payment, including a detailed sexual-health history and cardiovascular assessment.
How Welcuren works
Complete a short online consultation about your health and goals.
A clinician reviews your answers, may ask follow-up questions, and decides whether this treatment is appropriate for you.
You only pay once treatment is approved. Our licensed facility then dispatches it with full instructions, on tracked global delivery.
Safety
Bremelanotide is contraindicated in uncontrolled hypertension or known cardiovascular disease because it can transiently raise blood pressure. Nausea, flushing, headache and sometimes persistent focal hyperpigmentation occur; pregnancy and delayed absorption of oral medicines require review, and your clinician will advise
Questions
What is the precise US licensed population?
The authorised indication concerns premenopausal women with acquired, generalised HSDD, after other explanatory factors are excluded.
Is PT-141 licensed in the USA for erectile dysfunction?
The bremelanotide authorisation does not cover erectile dysfunction or male sexual-performance enhancement.
Why is blood pressure checked?
Transient blood-pressure increases are a known pharmacological effect, making cardiovascular screening important.
Can skin darkening persist?
Focal hyperpigmentation has been reported and does not always resolve after discontinuation.
This information is educational and not a substitute for advice from your clinician. Prescription treatments are only supplied after a clinical consultation.
Often considered together
Many clients start with a blood test so their clinician has a full picture.
Gonadorelin 2mgGonadorelin 2mg
A synthetic version of natural GnRH used in specific endocrine settings, not an established general libido or testosterone option.
Kisspeptin-10Kisspeptin-10
A short KISS1-derived peptide involved in reproductive hormone signalling, with exploratory human studies rather than established intimacy benefits.